Featured
-
-
News & Views |
Decision tree model has potential to improve NSGCT management
Patients diagnosed with clinical stage I (CS I) nonseminomatous germ cell tumors (NSGCT) have excellent survival. There are several therapies that contribute to this outcome and choosing among them can be challenging for both patient and physician. A decision tree analytical approach has been proposed, which incorporates quality of life outcomes and survival data to quantitatively determine the optimal approach for individual patients with CS I NSGCT.
- Ornob P. Roy
- & Louis R. Kavoussi
-
-
Case Study |
False elevation of human chorionic gonadotropin in a patient with testicular cancer
The authors describe a patient with a persistently elevated level of human chorionic gonadotropin (hCG) during chemotherapy for suspected low-risk, metastatic nonseminomatous germ cell tumor. His hCG level was found to have been falsely elevated owing to the presence of heterophile antibodies that interfered with the hCG immunoassay.
- David J. Gallagher
- , Jamie Riches
- & Dean F. Bajorin
-